61 related articles for article (PubMed ID: 8063241)
21. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
22. [Hereditary non-polyposis colorectal cancer].
Svendsen LB; Søndergaard JO; Bernstein IT; Bisgaard ML; Myrhøj T; Bülow S
Ugeskr Laeger; 1992 Mar; 154(14):917-20. PubMed ID: 1580000
[TBL] [Abstract][Full Text] [Related]
23. [Hereditary non polyposis colorectal cancer (HNPCC). A clinical and genetic entity].
Bertolaccini L; Olivero G
Minerva Chir; 2002 Feb; 57(1):63-72. PubMed ID: 11832861
[TBL] [Abstract][Full Text] [Related]
24. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
[TBL] [Abstract][Full Text] [Related]
25. [Essential to discover hereditary colorectal and endometrial cancer. Mutations in "HNPCC individuals" can cause several different tumors].
Nilbert M; Grönberg H; Lindblom A
Lakartidningen; 2002 Aug; 99(34):3296-300. PubMed ID: 12362848
[TBL] [Abstract][Full Text] [Related]
26. [Endometrial cancer in HNPCC syndrome].
Lécuru F; Ansquer Y; Bats AS; Olschwang S; Laurent-Puig P; Eisinger F
J Gynecol Obstet Biol Reprod (Paris); 2008 Oct; 37(6):547-53. PubMed ID: 18650032
[TBL] [Abstract][Full Text] [Related]
27. Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree.
Ponz de Leon M; Benatti P; Percesepe A; Rossi G; Viel A; Santarosa M; Pedroni M; Roncucci L
Ital J Gastroenterol Hepatol; 1999; 31(6):476-80. PubMed ID: 10575566
[TBL] [Abstract][Full Text] [Related]
28. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
29. [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].
Möslein G
Praxis (Bern 1994); 2001 Mar; 90(12):483-9. PubMed ID: 11324307
[TBL] [Abstract][Full Text] [Related]
30. Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.
Taylor N; Mutch DG
Oncology (Williston Park); 2006 Jan; 20(1):85-94; discussion 94-6, 100. PubMed ID: 16572595
[TBL] [Abstract][Full Text] [Related]
31. Genetics, natural history, surveillance, management, and gene mapping in the Lynch syndrome.
Lynch HT; Lynch J
Pathol Biol (Paris); 1995 Mar; 43(3):151-8. PubMed ID: 7675541
[TBL] [Abstract][Full Text] [Related]
32. Lynch syndrome.
Backes FJ; Cohn DE
Clin Obstet Gynecol; 2011 Jun; 54(2):199-214. PubMed ID: 21508689
[TBL] [Abstract][Full Text] [Related]
33. [Familial neoplastic syndromes of the ovary. A family study].
Di Vagno G; Nacci G; Cormio G; Loverro G
Minerva Ginecol; 1994 Oct; 46(10):571-4. PubMed ID: 7838415
[TBL] [Abstract][Full Text] [Related]
34. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.
Meyer LA; Broaddus RR; Lu KH
Cancer Control; 2009 Jan; 16(1):14-22. PubMed ID: 19078925
[TBL] [Abstract][Full Text] [Related]
35. Gynecologic Cancers in Lynch Syndrome/HNPCC.
Lu KH; Broaddus RR
Fam Cancer; 2005; 4(3):249-54. PubMed ID: 16136386
[TBL] [Abstract][Full Text] [Related]
36. Women with HNPCC: a target population for the chemoprevention of gynecologic cancers.
Broaddus RR; Lu KH
Front Biosci; 2006 Sep; 11():2077-80. PubMed ID: 16720294
[TBL] [Abstract][Full Text] [Related]
37. The Lynch syndromes.
Lynch HT; Lynch JF
Curr Opin Oncol; 1993 Jul; 5(4):687-96. PubMed ID: 8364086
[TBL] [Abstract][Full Text] [Related]
38. Lynch Syndrome and Endometrial Cancer.
Singh S; Resnick KE
South Med J; 2017 Apr; 110(4):265-269. PubMed ID: 28376523
[TBL] [Abstract][Full Text] [Related]
39. Follow-up recommendations and risk-reduction initiatives for Lynch syndrome.
Guillén-Ponce C; Molina-Garrido MJ; Carrato A
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1359-67. PubMed ID: 23176623
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation.
Lynch HT; Smyrk T; Lynch JF
Oncology; 1998; 55(2):103-8. PubMed ID: 9499183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
